Table of Contents
ISRN Hepatology
Volume 2013, Article ID 740149, 14 pages
http://dx.doi.org/10.1155/2013/740149
Review Article

Pathophysiological Significance of Hepatic Apoptosis

1Departments of Surgery and Pediatrics, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA
2Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China

Received 24 November 2012; Accepted 13 December 2012

Academic Editors: M. G. Mancino and J. J. Marin

Copyright © 2013 Kewei Wang and Bingliang Lin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Kerr, A. H. Wyllie, and A. R. Currie, “Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics,” British Journal of Cancer, vol. 26, no. 4, pp. 239–257, 1972. View at Google Scholar · View at Scopus
  2. A. H. Wyllie, “Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation,” Nature, vol. 284, no. 5756, pp. 555–556, 1980. View at Google Scholar · View at Scopus
  3. V. A. Krutovskikh, C. Piccoli, and H. Yamasaki, “Gap junction intercellular communication propagates cell death in cancerous cells,” Oncogene, vol. 21, no. 13, pp. 1989–1999, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Kroemer, L. Galluzzi, P. Vandenabeele et al., “Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009,” Cell Death and Differentiation, vol. 16, no. 1, pp. 3–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. P. Bechmann, G. Marquitan, C. Jochum, F. Saner, G. Gerken, and A. Canbay, “Apoptosis versus necrosis rate as a predictor in acute liver failure following acetaminophen intoxication compared with acute-on-chronic liver failure,” Liver International, vol. 28, no. 5, pp. 713–716, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Weingärtner, K. Lotz, A. Faltermeier et al., “The role of apoptosis in early embryonic development of the adenohypophysis in rats,” Head and Face Medicine, vol. 4, no. 1, article 13, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Miyoshi, H. Oubrahim, P. B. Chock, and E. R. Stadtman, “Age-dependent cell death and the role of ATP in hydrogen peroxide-induced apoptosis and necrosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 6, pp. 1727–1731, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Elmore, “Apoptosis: a review of programmed Cell Death,” Toxicologic Pathology, vol. 35, no. 4, pp. 495–516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Kmieć, “Cooperation of liver cells in health and disease,” Advances in Anatomy, Embryology and Cell Biology, vol. 161, no. 3–13, pp. 1–151, 2001. View at Google Scholar
  10. D. Fu, J. Lippincott-Schwartz, and I. M. Arias, “Cellular mechanism of bile acid-accelerated hepatocyte polarity,” Small GTPase, vol. 2, no. 6, pp. 314–317, 2011. View at Google Scholar
  11. T. Claudel, G. Zollner, M. Wagner, and M. Trauner, “Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease,” Biochimica et Biophysica Acta, vol. 1812, no. 8, pp. 867–878, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. E. Sirica, M. H. Nathanson, G. J. Gores, and N. F. LaRusso, “Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference,” Hepatology, vol. 48, no. 6, pp. 2040–2046, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Mazumdar, K. Meyer, and R. Ray, “N-terminal region of gelsolin induces apoptosis of activated hepatic stellate cells by a caspase-dependent mechanism,” PLoS ONE, vol. 7, no. 8, Article ID e44461, 2012. View at Google Scholar
  14. L. D. DeLeve, “Hepatic microvasculature in liver injury,” Seminars in Liver Disease, vol. 27, no. 4, pp. 390–400, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Racanelli and B. Rehermann, “The liver as an immunological organ,” Hepatology, vol. 43, supplement 1, no. 2, pp. S54–S62, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Wang, M. Foster, M. Al-Dhalimy, E. Lagasse, M. Finegold, and M. Grompe, “The origin and liver repopulating capacity of murine oval cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, supplement 2, pp. 11881–11888, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Ogasawara, R. Watanabe-Fukunaga, M. Adachi et al., “Lethal effect of the anti-Fas antibody in mice,” Nature, vol. 364, no. 6440, pp. 806–809, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Canbay, S. Friedman, and G. J. Gores, “Apoptosis: the nexus of liver injury and fibrosis,” Hepatology, vol. 39, no. 2, pp. 273–278, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Ghavami, M. Hashemi, K. Kadkhoda, S. M. Alavian, G. H. Bay, and M. Los, “Apoptosis in liver diseases—detection and therapeutic applications,” Medical Science Monitor, vol. 11, no. 11, pp. 337–345, 2005. View at Google Scholar · View at Scopus
  20. J. B. Chakraborty, F. Oakley, and M. J. Walsh, “Mechanisms and biomarkers of apoptosis in liver disease and fibrosis,” International Journal of Hepatology, vol. 2012, Article ID 648915, 10 pages, 2012. View at Google Scholar
  21. D. P. Bogdanos, G. Mieli-Vergani, and D. Vergani, “Virus, liver and autoimmunity,” Digestive and Liver Disease, vol. 32, no. 5, pp. 440–446, 2000. View at Google Scholar · View at Scopus
  22. L. Leggio, A. Ferrulli, A. Zambon et al., “Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection,” Addictive Behaviors, vol. 37, no. 4, pp. 561–564, 2012. View at Google Scholar
  23. N. Chalasani, “Statins and hepatotoxicity: focus on patients with fatty liver,” Hepatology, vol. 41, no. 4, pp. 690–695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. W. M. Lee, “Drug-induced hepatotoxicity,” The New England Journal of Medicine, vol. 349, no. 5, pp. 474–485, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Runyan, K. Schaible, K. Molyneaux, Z. Wang, L. Levin, and C. Wylie, “Steel factor controls midline cell death of primordial germ cells and is essential for their normal proliferation and migration,” Development, vol. 133, no. 24, pp. 4861–4869, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. L. M. Kulik, B. I. Carr, M. F. Mulcahy et al., “Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis,” Hepatology, vol. 47, no. 1, pp. 71–81, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Jaeschke, A. Farhood, S. X. Cai, B. Y. Tseng, and M. L. Bajt, “Protection against TNF-induced liver parenchymal cell apoptosis during endotoxemia by a novel caspase inhibitor in mice,” Toxicology and Applied Pharmacology, vol. 169, no. 1, pp. 77–83, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Machida, K. Tsukiyama-Kohara, E. Seike et al., “Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins,” Journal of Biological Chemistry, vol. 276, no. 15, pp. 12140–12146, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Zhao and S. A. Duncan, “Embryonic development of the liver,” Hepatology, vol. 41, no. 5, pp. 956–967, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. H. R. Horvitz, “Genetic control of programmed cell death in the nematode Caenorhabditis elegans,” Cancer Research, vol. 59, no. 7, pp. 1701–1706, 1999. View at Google Scholar · View at Scopus
  31. M. O. Hengartner, “Programmed cell death in the nematode C. elegans,” Recent Progress in Hormone Research, vol. 54, pp. 213–222, 1999. View at Google Scholar · View at Scopus
  32. M. Woo, R. Hakem, and T. W. Mak, “Executionary pathway for apoptosis: lessons from mutant mice,” Cell Research, vol. 10, no. 4, pp. 267–278, 2000. View at Google Scholar · View at Scopus
  33. S. B. Bratton, M. MacFarlane, K. Cain, and G. M. Cohen, “Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis,” Experimental Cell Research, vol. 256, no. 1, pp. 27–33, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Ratziu, M. Y. Sheikh, A. J. Sanyal et al., “A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis,” Hepatology, vol. 55, no. 2, pp. 419–428, 2012. View at Google Scholar
  35. D. S. Chelur and M. Chalfie, “Targeted cell killing by reconstituted caspases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 7, pp. 2283–2288, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. T. J. Fan, L. H. Han, R. S. Cong, and J. Liang, “Caspase family proteases and apoptosis,” Acta Biochimica et Biophysica Sinica, vol. 37, no. 11, pp. 719–727, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Nicotera and G. Melino, “Caspase-14 and epidermis maturation,” Nature Cell Biology, vol. 9, no. 6, pp. 621–622, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Ashkenazi and V. M. Dixit, “Death receptors: signaling and modulation,” Science, vol. 281, no. 5381, pp. 1305–1308, 1998. View at Google Scholar · View at Scopus
  39. D. R. Green and J. C. Reed, “Mitochondria and apoptosis,” Science, vol. 281, no. 5381, pp. 1309–1312, 1998. View at Google Scholar · View at Scopus
  40. E. E. Varfolomeev, M. Schuchmann, V. Luria et al., “Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally,” Immunity, vol. 9, no. 2, pp. 267–276, 1998. View at Google Scholar · View at Scopus
  41. K. Kuida, T. F. Haydar, C. Y. Kuan et al., “Reduced apoptosis and cytochrome C-mediated caspase activation in mice lacking caspase 9,” Cell, vol. 94, no. 3, pp. 325–337, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Kulda, T. S. Zheng, S. Na et al., “Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice,” Nature, vol. 384, no. 6607, pp. 368–372, 1996. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Gomyo, J. I. Sasaki, C. Branch, J. A. Roth, and T. Mukhopadhyay, “5-Aza-2'-deoxycytidine upregulates caspase-9 expression cooperating with p53-induced apoptosis in human lung cancer cells,” Oncogene, vol. 23, no. 40, pp. 6779–6787, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Schroter, K. Burns, C. Mattmann, D. Rimoldi, L. E. French, and J. Tschopp, “Inhibition of death receptor signals by cellular FLIP,” Nature, vol. 388, no. 6638, pp. 190–195, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Koseki, N. Inohara, S. Chen, and G. Núñez, “ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 9, pp. 5156–5160, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. L. Yang and X. M. Li, “The IAP family: endogenous caspase inhibitors with multiple biological activities,” Cell Research, vol. 10, no. 3, pp. 169–177, 2000. View at Google Scholar · View at Scopus
  47. J. Mei, S. Webb, B. Zhang, and H. B. Shu, “The p53-inducible apoptotic protein AMID is not required for normal development and tumor suppression,” Oncogene, vol. 25, no. 6, pp. 849–856, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Bertin, R. C. Armstrong, S. Ottilie et al., “Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 4, pp. 1172–1176, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Schneider, M. Thome, K. Burns et al., “TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB,” Immunity, vol. 7, no. 6, pp. 831–836, 1997. View at Publisher · View at Google Scholar · View at Scopus
  50. F. C. Kischkel, S. Hellbardt, I. Behrmann et al., “Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor,” The EMBO Journal, vol. 14, no. 22, pp. 5579–5588, 1995. View at Google Scholar · View at Scopus
  51. C. Scaffidi, S. Fulda, A. Srinivasan et al., “Two CD95 (APO-1/Fas) signaling pathways,” The EMBO Journal, vol. 17, no. 6, pp. 1675–1687, 1998. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Sadun, “Acquired mitochondrial impairment as a cause of optic nerve disease,” Transactions of the American Ophthalmological Society, vol. 96, pp. 881–923, 1998. View at Google Scholar · View at Scopus
  53. B. Fromenty and D. Pessayre, “Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity,” Pharmacology and Therapeutics, vol. 67, no. 1, pp. 101–154, 1995. View at Publisher · View at Google Scholar · View at Scopus
  54. C. A. Bradham, T. Qian, K. Streetz, C. Trautwein, D. A. Brenner, and J. J. Lemasters, “The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release,” Molecular and Cellular Biology, vol. 18, no. 11, pp. 6353–6364, 1998. View at Google Scholar · View at Scopus
  55. A. M. Verhagen, P. G. Ekert, M. Pakusch et al., “Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins,” Cell, vol. 102, no. 1, pp. 43–53, 2000. View at Google Scholar · View at Scopus
  56. L. Y. Li, X. Luo, and X. Wang, “Endonuclease G is an apoptotic DNase when released from mitochondria,” Nature, vol. 412, no. 6842, pp. 95–99, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Acehan, X. Jiang, D. G. Morgan, J. E. Heuser, X. Wang, and C. W. Akey, “Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation,” Molecular Cell, vol. 9, no. 2, pp. 423–432, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. E. A. Slee, M. T. Harte, R. M. Kluck et al., “Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2,-3,-6,-7,-8, and -10 in a caspase-9-dependent manner,” Journal of Cell Biology, vol. 144, no. 2, pp. 281–292, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Hikita, T. Takehara, T. Kodama et al., “BH3-only protein bid participates in the Bcl-2 network in healthy liver cells,” Hepatology, vol. 50, no. 6, pp. 1972–1980, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. X. M. Yin and W. X. Ding, “Death receptor activation-induced hepatocyte apoptosis and liver injury,” Current Molecular Medicine, vol. 3, no. 6, pp. 491–508, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. J. C. Ameisen, “On the origin, evolution, and nature of programmed cell death: a timeline of four billion years,” Cell Death and Differentiation, vol. 9, no. 4, pp. 367–393, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. M. C. Raff, B. A. Barres, J. F. Burne, H. S. Coles, Y. Ishizaki, and M. D. Jacobson, “Programmed cell death and the control of cell survival: lessons from the nervous system,” Science, vol. 262, no. 5134, pp. 695–700, 1993. View at Google Scholar · View at Scopus
  63. P. P. Sfikakis, “The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions,” Current Directions in Autoimmunity, vol. 11, pp. 180–210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. J. A. Flygare, M. Beresini, N. Budha et al., “Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152),” Journal of Medicinal Chemistry, vol. 55, no. 9, pp. 4101–4113, 2012. View at Google Scholar
  65. Y. Vodovotz, P. K. M. Kim, E. Z. Bagci et al., “Inflammatory modulation of hepatocyte apoptosis by nitric oxide: in vivo, in vitro, and in silico studies,” Current Molecular Medicine, vol. 4, no. 7, pp. 753–762, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. L. Ghibelli and M. Diederich, “Multistep and multitask Bax activation,” Mitochondrion, vol. 10, no. 6, pp. 604–613, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. G. Wu, J. Chai, T. L. Suber et al., “Structural basis of IAP recognition by Smac/DIABLO,” Nature, vol. 408, no. 6815, pp. 1008–1012, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. L. M. Martins, A. Morrison, K. Klupsch et al., “Neuroprotective role of the reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice,” Molecular and Cellular Biology, vol. 24, no. 22, pp. 9848–9862, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. G. S. Salvesen and C. S. Duckett, “IAP proteins: blocking the road to death's door,” Nature Reviews Molecular Cell Biology, vol. 3, no. 6, pp. 401–410, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. R. Takahashi, Q. Deveraux, I. Tamm et al., “A single BIR domain of XIAP sufficient for inhibiting caspases,” Journal of Biological Chemistry, vol. 273, no. 14, pp. 7787–7790, 1998. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. Huang, Y. C. Park, R. L. Rich, D. Segal, D. G. Myszka, and H. Wu, “Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain,” Cell, vol. 104, no. 5, pp. 781–790, 2001. View at Google Scholar · View at Scopus
  72. S. M. Srinivasula, R. Hegde, A. Saleh et al., “A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis,” Nature, vol. 410, no. 6824, pp. 112–116, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. Q. L. Deveraux, N. Roy, H. R. Stennicke et al., “IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases,” The EMBO Journal, vol. 17, no. 8, pp. 2215–2223, 1998. View at Publisher · View at Google Scholar · View at Scopus
  74. N. Roy, Q. L. Deveraux, R. Takahashi, G. S. Salvesen, and J. C. Reed, “The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases,” The EMBO Journal, vol. 16, no. 23, pp. 6914–6925, 1997. View at Google Scholar · View at Scopus
  75. B. P. Eckelman and G. S. Salvesen, “The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases,” Journal of Biological Chemistry, vol. 281, no. 6, pp. 3254–3260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. E. Varfolomeev, J. W. Blankenship, S. M. Wayson et al., “IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis,” Cell, vol. 131, no. 4, pp. 669–681, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. C. Du, M. Fang, Y. Li, L. Li, and X. Wang, “Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition,” Cell, vol. 102, no. 1, pp. 33–42, 2000. View at Google Scholar · View at Scopus
  78. H. K. Huang, C. A. P. Joazeiro, E. Bonfoco, S. Kamada, J. D. Leverson, and T. Hunter, “The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7,” Journal of Biological Chemistry, vol. 275, no. 35, pp. 26661–26664, 2000. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. Suzuki, Y. Nakabayashi, K. Nakata, J. C. Reed, and R. Takahashi, “X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes,” Journal of Biological Chemistry, vol. 276, no. 29, pp. 27058–27063, 2001. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Lopez and P. Meier, “To fight or die-inhibitor of apoptosis proteins at the crossroad of innate immunity and death,” Current Opinion in Cell Biology, vol. 22, no. 6, pp. 872–881, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Danson, E. Dean, C. Dive, and M. Ranson, “IAPs as a target for anticancer therapy,” Current Cancer Drug Targets, vol. 7, no. 8, pp. 785–794, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. A. K. Udit, W. Belliston-Bittner, E. C. Glazer et al., “Redox couples of inducible nitric oxide synthase,” Journal of the American Chemical Society, vol. 127, no. 32, pp. 11212–11213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Li and T. R. Billiar, “Nitric oxide IV. Determinants of nitric oxide protection and toxicity in liver,” American Journal of Physiology, vol. 276, no. 5, pp. G1069–G1073, 1999. View at Google Scholar · View at Scopus
  84. B. S. Taylor, L. H. Alarcon, and T. R. Billiar, “Inducible nitric oxide synthase in the liver: regulation and function,” Biochemistry, vol. 63, no. 7, pp. 766–781, 1998. View at Google Scholar · View at Scopus
  85. C. V. Rao, “Nitric oxide signaling in colon cancer chemoprevention,” Mutation Research, vol. 555, no. 1-2, pp. 107–119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. D. A. Geller, P. D. Freeswick, D. Nguyen et al., “Differential induction of nitric oxide synthase in hepatocytes during endotoxemia and the acute-phase response,” Archives of Surgery, vol. 129, no. 2, pp. 165–171, 1994. View at Google Scholar · View at Scopus
  87. K. Wang, J. J. Brems, R. L. Gamelli, and A. X. Holterman, “INOS/NO signaling regulates apoptosis induced by glycochenodeoxycholate in hepatocytes,” Cellular Signalling, vol. 23, no. 10, pp. 1677–1685, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. K. Wang, J. J. Brems, R. L. Gamelli, and A. X. Holterman, “C/EBPα and C/EBPβ binding proteins modulate hepatocyte apoptosis through iNOS signaling pathway,” Biochimica et biophysica acta, vol. 1813, no. 8, pp. 1395–1403, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. Y. M. Kim, R. V. Talanian, and T. R. Billiar, “Nitric oxide inhibits apoptosis by preventing increases in caspase-3- like activity via two distinct mechanisms,” Journal of Biological Chemistry, vol. 272, no. 49, pp. 31138–31148, 1997. View at Publisher · View at Google Scholar · View at Scopus
  90. E. Tzeng, Y. M. Kim, B. R. Pitt, A. Lizonova, I. Kovesdi, and T. R. Billiar, “Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis,” Surgery, vol. 122, no. 2, pp. 255–263, 1997. View at Publisher · View at Google Scholar · View at Scopus
  91. H. T. Chung, H. O. Pae, B. M. Choi, T. R. Billiar, and Y. M. Kim, “Nitric oxide as a bioregulator of apoptosis,” Biochemical and Biophysical Research Communications, vol. 282, no. 5, pp. 1075–1079, 2001. View at Google Scholar
  92. Y. M. Kim, T. H. Kim, D. W. Seol, R. V. Talanian, and T. R. Billiar, “Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release,” Journal of Biological Chemistry, vol. 273, no. 47, pp. 31437–31441, 1998. View at Publisher · View at Google Scholar · View at Scopus
  93. Y. M. Kim, T. H. Kim, H. T. Chung, R. V. Talanian, X. M. Yin, and T. R. Billiar, “Nitric oxide prevents tumor necrosis factor α-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8,” Hepatology, vol. 32, no. 4, pp. 770–778, 2000. View at Google Scholar · View at Scopus
  94. B. M. Choi, H. O. Pae, S. I. Jang, Y. M. Kim, and H. T. Chung, “Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator,” Journal of Biochemistry and Molecular Biology, vol. 35, no. 1, pp. 116–126, 2002. View at Google Scholar · View at Scopus
  95. H. H. H. W. Schmidt and U. Walter, “NO at work,” Cell, vol. 78, no. 6, pp. 919–925, 1994. View at Publisher · View at Google Scholar · View at Scopus
  96. D. L. Vaux, S. Cory, and J. M. Adams, “Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells,” Nature, vol. 335, no. 6189, pp. 440–442, 1988. View at Google Scholar · View at Scopus
  97. C. Borner, “The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions,” Molecular Immunology, vol. 39, no. 11, pp. 615–647, 2003. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Giam, D. C. S. Huang, and P. Bouillet, “BH3-only proteins and their roles in programmed cell death,” Oncogene, vol. 27, supplement 1, pp. S128–S136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. T. Mund, A. Gewies, N. Schoenfeld, M. K. Bauer, and S. Grimm, “Spike, a novel BH3-only protein, regulates apoptosis at the endoplasmic reticulum,” The FASEB Journal, vol. 17, no. 6, pp. 696–698, 2003. View at Google Scholar · View at Scopus
  100. R. M. Kluck, E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer, “The release of cytochrome c from mitochondria: a primary site for Bcl- 2 regulation of apoptosis,” Science, vol. 275, no. 5303, pp. 1132–1136, 1997. View at Publisher · View at Google Scholar · View at Scopus
  101. J. Yang, X. Liu, K. Bhalla et al., “Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked,” Science, vol. 275, no. 5303, pp. 1129–1132, 1997. View at Publisher · View at Google Scholar · View at Scopus
  102. V. S. Marsden, L. O'Connor, L. A. O'Reilly et al., “Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome,” Nature, vol. 419, no. 6907, pp. 634–637, 2002. View at Publisher · View at Google Scholar · View at Scopus
  103. A. Nechushtan, C. L. Smith, I. Lamensdorf, S. H. Yoon, and R. J. Youle, “Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis,” Journal of Cell Biology, vol. 153, no. 6, pp. 1265–1276, 2001. View at Publisher · View at Google Scholar · View at Scopus
  104. B. Antonsson, S. Montessuit, S. Lauper, R. Eskes, and J. C. Martinou, “Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria,” Biochemical Journal, vol. 345, pp. 271–278, 2000. View at Publisher · View at Google Scholar · View at Scopus
  105. Y. Tsujimoto and S. Shimizu, “VDAC regulation by the Bcl-2 family of proteins,” Cell Death and Differentiation, vol. 7, no. 12, pp. 1174–1181, 2000. View at Publisher · View at Google Scholar · View at Scopus
  106. J. C. Reed, “Bcl-2 family proteins,” Oncogene, vol. 17, no. 25, pp. 3225–3236, 1998. View at Google Scholar · View at Scopus
  107. M. Marcelli, G. R. Cunningham, M. Walkup et al., “Signaling pathway activated during apoptosis of the prostate cancer celt line LNCaP: overexpression of caspase-7 as a new gene therapy strategy for prostate cancer,” Cancer Research, vol. 59, no. 2, pp. 382–390, 1999. View at Google Scholar · View at Scopus
  108. C. A. Heckman, J. W. Mehew, and L. M. Boxer, “NF-κb activates Bcl-2 expression in t(14;18) lymphoma cells,” Oncogene, vol. 21, no. 24, pp. 3898–3908, 2002. View at Publisher · View at Google Scholar · View at Scopus
  109. M. Karin and A. Lin, “NF-κB at the crossroads of life and death,” Nature Immunology, vol. 3, no. 3, pp. 221–227, 2002. View at Google Scholar
  110. S. R. Datta, A. Brunet, and M. E. Greenberg, “Cellular survival: a play in three akts,” Genes and Development, vol. 13, no. 22, pp. 2905–2927, 1999. View at Publisher · View at Google Scholar · View at Scopus
  111. K. Wang, J. J. Brems, R. L. Gamelli, and A. X. Holterman, “Survivin signaling is regulated through nuclear factor-kappa B pathway during glycochenodeoxycholate-induced hepatocyte apoptosis,” Biochimica et Biophysica Acta, vol. 1803, no. 12, pp. 1368–1375, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. O. Schon, A. Friedler, M. Bycroft, S. M. V. Freund, and A. R. Fersht, “Molecular mechanism of the interaction between MDM2 and p53,” Journal of Molecular Biology, vol. 323, no. 3, pp. 491–501, 2002. View at Publisher · View at Google Scholar · View at Scopus
  113. W. H. Hoffman, S. Biade, J. T. Zilfou, J. Chen, and M. Murphy, “Transcriptional repression of the anti-apoptotic survivin gene by wild type p53,” Journal of Biological Chemistry, vol. 277, no. 5, pp. 3247–3257, 2002. View at Publisher · View at Google Scholar · View at Scopus
  114. Y. Wu, J. W. Mehew, C. A. Heckman, M. Arcinas, and L. M. Boxer, “Negative regulation of bcl-2 expression by p53 in hematopoietic cells,” Oncogene, vol. 20, no. 2, pp. 240–251, 2001. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Mihara, S. Erster, A. Zaika et al., “p53 has a direct apoptogenic role at the mitochondria,” Molecular Cell, vol. 11, no. 3, pp. 577–590, 2003. View at Publisher · View at Google Scholar · View at Scopus
  116. T. Mahdi, D. Alcalay, C. Cognard, J. Tanzer, and A. Kitzis, “Rescue of K562 cells from MDM2-modulated p53-dependent apoptosis by growth factor-induced differentiation,” Biology of the Cell, vol. 90, no. 9, pp. 615–627, 1998. View at Publisher · View at Google Scholar · View at Scopus
  117. K. M. Nicholson and N. G. Anderson, “The protein kinase B/Akt signalling pathway in human malignancy,” Cellular Signalling, vol. 14, no. 5, pp. 381–395, 2002. View at Publisher · View at Google Scholar · View at Scopus
  118. M. Henriksson, G. Selivanova, M. Lindström, and K. G. Wiman, “Inactivation of Myc-induced p53-dependent apoptosis in human tumors,” Apoptosis, vol. 6, no. 1-2, pp. 133–137, 2001. View at Publisher · View at Google Scholar · View at Scopus
  119. F. Melchior and L. Hengst, “SUMO-1 and p53,” Cell Cycle, vol. 1, no. 4, pp. 245–249, 2002. View at Google Scholar · View at Scopus
  120. E. Appella, “Modulation of p53 function in cellular regulation,” European Journal of Biochemistry, vol. 268, no. 10, p. 2763, 2001. View at Publisher · View at Google Scholar · View at Scopus
  121. N. Senzer, J. Nemunaitis, M. Nemunaitis et al., “p53 therapy in a patient with Li-Fraumeni syndrome,” Molecular Cancer Therapeutics, vol. 6, no. 5, pp. 1478–1482, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. P. Hainaut and M. Hollstein, “p53 and human cancer: the first ten thousand mutations,” Advances in Cancer Research, vol. 77, pp. 81–137, 2000. View at Google Scholar · View at Scopus
  123. M. Müller, S. Strand, H. Hug et al., “Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53,” Journal of Clinical Investigation, vol. 99, no. 3, pp. 403–413, 1997. View at Google Scholar · View at Scopus
  124. T. Kodama, T. Takehara, H. Ishida et al., “Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice,” Journal of Clinical Investigation, vol. 121, no. 8, pp. 3343–3356, 2011. View at Publisher · View at Google Scholar · View at Scopus
  125. K. Tomita, T. Teratani, T. Suzuki et al., “p53/p66Shc-mediated signaling contributes to the progression of nonalcoholic steatohepatitis in humans and mice,” Journal of Hepatology, vol. 57, no. 4, pp. 837–843. View at Publisher · View at Google Scholar
  126. T. Kouzarides and E. Ziff, “Behind the Fos and Jun leucine zipper,” Cancer Cells, vol. 1, no. 3, pp. 71–76, 1989. View at Google Scholar · View at Scopus
  127. D. Bohmann and R. Tjian, “Biochemical analysis of transcriptional activation by Jun: differential activity of c- and v-Jun,” Cell, vol. 59, no. 4, pp. 709–717, 1989. View at Google Scholar · View at Scopus
  128. Q. Meng and Y. Xia, “c-Jun, at the crossroad of the signaling network,” Protein-Cell, vol. 2, no. 11, pp. 889–898, 2011. View at Google Scholar
  129. A. Behrens, M. Sibilia, and E. F. Wagner, “Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation,” Nature Genetics, vol. 21, no. 3, pp. 326–329, 1999. View at Publisher · View at Google Scholar · View at Scopus
  130. T. Udou, T. Hachisuga, H. Tsujioka, and T. Kawarabayashi, “The role of c-Jun protein in proliferation and apoptosis of the endometrium throughout the menstrual cycle,” Gynecologic and Obstetric Investigation, vol. 57, no. 3, pp. 121–126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  131. M. Fuest, K. Willim, S. MacNelly et al., “The transcription factor c-Jun protects against sustained hepatic endoplasmic reticulum stress thereby promoting hepatocyte survival,” Hepatology, vol. 55, no. 2, pp. 408–418, 2012. View at Google Scholar
  132. R. Eferl, R. Ricci, L. Kenner et al., “Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53,” Cell, vol. 112, no. 2, pp. 181–192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  133. F. Hilberg, A. Aguzzi, N. Howells, and E. F. Wagner, “c-Jun is essential for normal mouse development and hepatogenesis,” Nature, vol. 365, no. 6442, pp. 179–181, 1993. View at Publisher · View at Google Scholar · View at Scopus
  134. R. Eferl, M. Sibilia, F. Hilberg et al., “Functions of c-Jun in liver and heart development,” Journal of Cell Biology, vol. 145, no. 5, pp. 1049–1061, 1999. View at Publisher · View at Google Scholar · View at Scopus
  135. A. Behrens, M. Sibilia, J. P. David et al., “Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-Jun in the liver,” The EMBO Journal, vol. 21, no. 7, pp. 1782–1790, 2002. View at Publisher · View at Google Scholar · View at Scopus
  136. L. Hui, K. Zatloukal, H. Scheuch, E. Stepniak, and E. F. Wagner, “Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation,” Journal of Clinical Investigation, vol. 118, no. 12, pp. 3943–3953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  137. M. F. Yuen, P. C. Wu, V. C. Lai, J. Y. Lau, and C. L. Lai, “Expression of c-Myc, c-Fos, and c-Jun in hepatocellular carcinoma,” Cancer, vol. 91, pp. 106–112, 2001. View at Google Scholar
  138. R. Johnson, B. Spiegelman, D. Hanahan, and R. Wisdom, “Cellular transformation and malignancy induced by ras require c-Jun,” Molecular and Cellular Biology, vol. 16, no. 8, pp. 4504–4511, 1996. View at Google Scholar · View at Scopus
  139. M. Schreiber, A. Kolbus, F. Piu et al., “Control of cell cycle progression by c-Jun is p53 dependent,” Genes and Development, vol. 13, no. 5, pp. 607–619, 1999. View at Google Scholar · View at Scopus
  140. B. Knight, G. C. T. Yeoh, K. L. Husk et al., “Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice,” Journal of Experimental Medicine, vol. 192, no. 12, pp. 1809–1818, 2000. View at Publisher · View at Google Scholar · View at Scopus
  141. S. Kanzler, E. Meyer, A. W. Lohse et al., “Hepatocellular expression of a dominant-negative mutant TGF-β type II receptor accelerates chemically induced hepatocarcinogenesis,” Oncogene, vol. 20, no. 36, pp. 5015–5024, 2001. View at Publisher · View at Google Scholar · View at Scopus
  142. R. M. Friedlander, “Apoptosis and caspases in neurodegenerative diseases,” The New England Journal of Medicine, vol. 348, no. 14, pp. 1365–1375, 2003. View at Publisher · View at Google Scholar · View at Scopus
  143. T. Scarabelli, A. Stephanou, N. Rayment et al., “Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury,” Circulation, vol. 104, no. 3, pp. 253–256, 2001. View at Google Scholar · View at Scopus
  144. S. Chabot, A. Fakhfakh, K. Béland et al., “Mouse liver-specific CD8(+) T-cells encounter their cognate antigen and acquire capacity to destroy target hepatocytes,” Journal of Autoimmunity. In press.
  145. J. A. Karam, Apoptosis in Carcinogenesis and Chemotherapy, Springer, Amsterdam, The Netherlands, 2009.
  146. B. Fadeel, S. Orrenius, and B. Zhivotovsky, “Apoptosis in human disease: a new skin for the old ceremony?” Biochemical and Biophysical Research Communications, vol. 266, no. 3, pp. 699–717, 1999. View at Publisher · View at Google Scholar · View at Scopus
  147. M. E. Guicciardi and G. J. Gores, “Apoptosis as a mechanism for liver disease progression,” Seminars in Liver Disease, vol. 30, no. 4, pp. 402–410, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. W. X. Ding and X. M. Yin, “Dissection of the multiple mechanisms of TNF-α-induced apoptosis in liver injury,” Journal of Cellular and Molecular Medicine, vol. 8, no. 4, pp. 445–454, 2004. View at Publisher · View at Google Scholar · View at Scopus
  149. C. K. Ayata, S. C. Ganal, B. Hockenjos et al., “Purinergic P2Y2 receptors promote neutrophil infiltration and hepatocyte death in mice with acute liver injury,” Gastroenterology, vol. 143, no. 6, pp. 1620.e4–1629.e4, 2012. View at Publisher · View at Google Scholar
  150. C. Girish, B. C. Koner, S. Jayanthi, K. Ramachandra Rao, B. Rajesh, and S. C. Pradhan, “Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice,” Journal of Pharmacology and Pharmacotherapeutics, vol. 3, no. 2, pp. 149–155, 2012. View at Google Scholar
  151. C. Liedtke, J. M. Bangen, J. Freimuth et al., “Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury,” Gastroenterology, vol. 141, no. 6, pp. 2176–2187, 2011. View at Google Scholar
  152. W. J. Kaiser, J. W. Upton, A. B. Long et al., “RIP3 mediates the embryonic lethality of caspase-8-deficient mice,” Nature, vol. 471, no. 7338, pp. 368–372, 2011. View at Google Scholar · View at Scopus
  153. T. Takehara, T. Tatsumi, T. Suzuki et al., “Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses,” Gastroenterology, vol. 127, no. 4, pp. 1189–1197, 2004. View at Publisher · View at Google Scholar · View at Scopus
  154. D. J. Pritchard and W. H. Butler, “Apoptosis—the mechanism of cell death in dimethylnitrosamine-induced hepatotoxicity,” Journal of Pathology, vol. 158, no. 3, pp. 253–260, 1989. View at Google Scholar · View at Scopus
  155. H. Miyoshi, C. Rust, P. J. Roberts, L. J. Burgart, and G. J. Gores, “Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas,” Gastroenterology, vol. 117, no. 3, pp. 669–677, 1999. View at Publisher · View at Google Scholar · View at Scopus
  156. W. Mehal and A. Imaeda, “Cell death and fibrogenesis,” Seminars in Liver Disease, vol. 30, no. 3, pp. 226–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  157. H. Malhi, G. J. Gores, and J. J. Lemasters, “Apoptosis and necrosis in the liver: a tale of two deaths?” Hepatology, vol. 43, supplement 2, pp. S31–S44, 2006. View at Google Scholar · View at Scopus
  158. A. Canbay, A. Feldstein, E. Baskin-Bey, S. F. Bronk, and G. J. Gores, “The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse,” Journal of Pharmacology and Experimental Therapeutics, vol. 308, no. 3, pp. 1191–1196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  159. A. Canbay, P. Taimr, N. Torok, H. Higuchi, S. Friedman, and G. J. Gores, “Apoptotic body engulfment by a human stellate cell line is profibrogenic,” Laboratory Investigation, vol. 83, no. 5, pp. 655–663, 2003. View at Google Scholar · View at Scopus
  160. G. N. Ioannou, C. L. Bryson, N. S. Weiss, R. Miller, J. D. Scott, and E. J. Boyko, “The prevalence of cirrhosis and hepatocellular carcinoma in patients with HIV infection,” Hepatology. In press.
  161. D. Jain, N. C. Nayak, and S. Saigal, “Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis: risk factor analysis in liver transplant recipients,” European Journal of Gastroenterology & Hepatology, vol. 24, no. 7, pp. 840–848, 2012. View at Google Scholar
  162. R. P. Witek, W. C. Stone, F. G. Karaca et al., “Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis,” Hepatology, vol. 50, no. 5, pp. 1421–1430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  163. H. C. Masuoka, M. E. Guicciardi, and G. J. Gores, “Caspase inhibitors for the treatment of hepatitis C,” Clinics in Liver Disease, vol. 13, no. 3, pp. 467–475, 2009. View at Publisher · View at Google Scholar · View at Scopus
  164. H. Hikita, T. Takehara, S. Shimizu et al., “Mcl-1 and Bcl-xL cooperatively maintain integrity of hepatocytes in developing and adult murine liver,” Hepatology, vol. 50, no. 4, pp. 1217–1226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  165. L. Müllauer, P. Gruber, D. Sebinger, J. Buch, S. Wohlfart, and A. Chott, “Mutations in apoptosis genes: a pathogenetic factor for human disease,” Mutation Research, vol. 488, no. 3, pp. 211–231, 2001. View at Publisher · View at Google Scholar · View at Scopus
  166. T. Patel, L. R. Roberts, B. A. Jones, and G. J. Gores, “Dysregulation of apoptosis as a mechanism of liver disease: an overview,” Seminars in Liver Disease, vol. 18, no. 2, pp. 105–114, 1998. View at Google Scholar · View at Scopus
  167. W. Wen, J. Ding, W. Sun et al., “Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression,” Hepatology, vol. 55, no. 6, pp. 1787–1798, 2012. View at Google Scholar
  168. X. W. Wang, “Role of p53 and apoptosis in carcinogenesis,” Anticancer Research, vol. 19, no. 6A, pp. 4759–4771, 1999. View at Google Scholar · View at Scopus
  169. F. He, L. Mo, X. Y. Zheng et al., “Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis,” Cancer Research, vol. 69, no. 24, pp. 9413–9421, 2009. View at Publisher · View at Google Scholar · View at Scopus
  170. D. Hockenbery, G. Nunez, C. Milliman, R. D. Schreiber, and S. J. Korsmeyer, “Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death,” Nature, vol. 348, no. 6299, pp. 334–336, 1990. View at Publisher · View at Google Scholar · View at Scopus
  171. Y. H. Kang, M. Y. Park, D. Y. Yoon et al., “Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2,” Cancer Letters, vol. 318, no. 2, pp. 226–233, 2012. View at Google Scholar
  172. S. Kondo, Y. Shinomura, Y. Miyazaki et al., “Mutations of the bak gene in human gastric and colorectal cancers,” Cancer Research, vol. 60, no. 16, pp. 4328–4330, 2000. View at Google Scholar · View at Scopus
  173. N. Rampino, H. Yamamoto, Y. Ionov et al., “Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype,” Science, vol. 275, no. 5302, pp. 967–969, 1997. View at Publisher · View at Google Scholar · View at Scopus
  174. C. Yin, C. M. Knudson, S. J. Korsmeyer, and T. Van Dyke, “Bax suppresses tumorigenesis and stimulates apoptosis in vivo,” Nature, vol. 385, no. 6617, pp. 637–640, 1997. View at Publisher · View at Google Scholar · View at Scopus
  175. D. A. Altomare and J. R. Testa, “Perturbations of the AKT signaling pathway in human cancer,” Oncogene, vol. 24, no. 50, pp. 7455–7464, 2005. View at Publisher · View at Google Scholar · View at Scopus
  176. K. M. Yamada and M. Araki, “Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis,” Journal of Cell Science, vol. 114, pp. 2375–2382, 2001. View at Google Scholar · View at Scopus
  177. L. E. Nelson, R. J. Valentine, J. M. Cacicedo, M. S. Gauthier, Y. Ido, and N. B. Ruderman, “A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells,” American Journal of Physiology, vol. 303, no. 1, pp. C4–C13, 2012. View at Google Scholar
  178. R. Quiles-Perez, J. A. Muñoz-Gámez, A. Ruiz-Extremera et al., “Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression,” Hepatology, vol. 51, no. 1, pp. 255–266, 2010. View at Google Scholar
  179. E. K. Lee, D. G. Kim, J. S. Kim, and Y. Yoon, “Cell-cycle regulator Cks1 promotes hepatocellular carcinoma by supporting NF-κB-dependent expression of interleukin-8,” Cancer Research, vol. 71, no. 21, pp. 6827–6835, 2011. View at Google Scholar
  180. S. W. Lowe and A. W. Lin, “Apoptosis in cancer,” Carcinogenesis, vol. 21, no. 3, pp. 485–495, 2000. View at Google Scholar · View at Scopus
  181. B. Vick, A. Weber, T. Urbanik et al., “Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes,” Hepatology, vol. 49, no. 2, pp. 627–636, 2009. View at Publisher · View at Google Scholar · View at Scopus
  182. AASLD, “A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis,” in Proceedings of the AASLD 62nd Annual Liver Meeting, San Francisco, Calif, USA, November 2011.
  183. AASLD, “Inhibition of caspase activity with emricasan in HCV patients: potential implications for chronic dosing and long term safety,” in Proceedings of the AASLD 63rd Annual Liver Meeting, Boston, Mass, USA, November 2012.
  184. Q. Cai, H. Sun, Y. Peng et al., “A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment,” Journal of Medicinal Chemistry, vol. 54, no. 8, pp. 2714–2726, 2011. View at Publisher · View at Google Scholar · View at Scopus
  185. H. Harlin, S. Birkey Reffey, C. S. Duckett, T. Lindsten, and C. B. Thompson, “Characterization of XIAP-deficient mice,” Molecular and Cellular Biology, vol. 21, no. 10, pp. 3604–3608, 2001. View at Publisher · View at Google Scholar · View at Scopus